← All stocks

BiomX Inc.

PHGE Net buying
CIK 0001739174 #5600 in the set updated 19 Sep 2026
Bought (120 mo)
$785.89K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$8.58M
$0.00 on a plan · $8.26M straight out of an exercise
Sold at will
$322.16K
65 of 70 sales
Net
−$7.80M
+$463.73K against sales at will

By person

18 insiders · 104 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Yeganeh Reuven
Director
$8.25M (4) scheduled
−$8.25M
0
$0.00
Ugwumba Chidozie
Exit Form 4 - former 10% owner
$318.09K (62)
−$318.09K
2,997,025
$14.99M
−17.6%
OrbiMed Israel BioFund GP Limited Partnership entity
10% owner
$284.44K (9)
$9.28K (1) scheduled
+$275.16K
16,587,142
$82.94M
+156.8%
Chimovits Erez
Director
$199.18K (7)
+$199.18K
4,626,978
$23.13M
+0.5%
Solomon Jonathan Eitan
Chief Executive Officer
$100.00K (1)
+$100.00K
126,748
$633.74K
SEKHRI PAUL J
Director
$50.00K (1)
+$50.00K
12,500
$62.50K
Sullivan Lynne Marie
Director
$50.00K (1)
+$50.00K
12,500
$62.50K
GROSSMAN JONAS
Director
$49.24K (4)
+$49.24K
2,079,717
$10.40M
−39.1%
Moses Alan Charles
Director
$20.00K (1)
+$20.00K
5,000
$25.00K
Greig Russell
Director
$15.00K (1)
+$15.00K
3,750
$18.75K
Wolfson Marina
Chief Financial Officer
$15.00K (1)
+$15.00K
68,545
$342.73K
Oron Assaf
Chief Business Officer
$3.03K (3)
$4.07K (3)
−$1.04K
25,804
$129.02K
Amusa Gbolahan
Director
(1)
$0.00
262,871
$1.31M
Cystic Fibrosis Foundation entity
10% owner
9,330,580
$46.65M
+105.0%
Flynn James E
Director
1,247,054
$6.24M
PROPPER KERRY
10% owner
260,771
$1.30M
Bassan Merav
Chief Development Officer
79,597
$397.99K
Walton Thomas Layton
10% owner
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 2.9 over the window, from 10,111,516 to 29,006,165 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 121
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 5
Sales at will 65
Transactions with no price 3
Shares from compensation/vesting 42,932,639
Sales filed before the plan box existed 62
History held since 19 Dec 2018